Role of peroxisome proliferator-activated receptor-γ in the protection afforded by 15-deoxyΔ12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin
- 1 March 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 32 (3), 826-831
- https://doi.org/10.1097/01.ccm.0000114821.25573.e7
Abstract
The cyclopentenone prostaglandin 15-deoxydelta-prostaglandin J2 (15 d-PGJ2) exerts potent anti-inflammatory effects in vivo, which are in part due to the activation of peroxisome proliferator-activated receptor (PPAR)-gamma. Here we investigate the effects of 15 d-PGJ2 on the multiple organ injury/dysfunction associated with severe endotoxemia. Prospective, randomized study. University-based research laboratory. Seventy anesthetized male Wistar rats. Rats received either Escherichia coli lipopolysaccharide (endotoxin, 6 mg/kg intravenously) or vehicle (saline, 1 mL/kg intravenously). 15 d-PGJ2 (0.3 mg/kg intravenously) or vehicle (10% dimethyl sulfoxide) was administered 30 mins before endotoxin. The selective PPAR-gamma antagonist GW9662 (0.3 mg/kg intravenously) or its vehicle (10% dimethyl sulfoxide) was given 45 mins before endotoxin. Endotoxemia for 6 hrs increased serum concentrations of creatinine (indicator of renal dysfunction), aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase, bilirubin (markers for hepatic injury and dysfunction), lipase (indicator of pancreatic injury), and creatine kinase (an indicator of neuromuscular skeletal muscle or cardiac injury). The potent PPAR-gamma agonist 15 d-PGJ2 attenuated the increases in the serum concentrations of these variables, indicating a protective effect of 15 d-PGJ2 against the multiple organ injury/dysfunction caused by endotoxin. The specific PPAR-gamma antagonist GW9662 reduced the protective effects afforded by 15 d-PGJ2. 15 d-PGJ2 did not affect the biphasic decrease in blood pressure or the increase in heart rate caused by endotoxemia. The potent PPAR-gamma agonist 15 d-PGJ2 reduces the multiple organ injury and dysfunction, but not the hypotension, caused by endotoxin in the rat. The mechanisms of the protective effect of this cyclopentenone prostaglandin are--at least in part--PPAR-gamma dependent, as the protection afforded by 15 d-PGJ2 was reduced by the PPAR-gamma antagonist GW9662. We propose that 15 d-PGJ2 or other ligands for PPAR-gamma may be useful in treating organ injury associated with endotoxic shock.Keywords
This publication has 26 references indexed in Scilit:
- The cyclopentenone prostaglandin 15‐deoxy‐Δ12,14‐ PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the ratBritish Journal of Pharmacology, 2003
- Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct sizeThe FASEB Journal, 2002
- Carboxy-Ptio, a Scavenger of Nitric Oxide, Selectively Inhibits the Increase in Medullary Perfusion and Improves Renal Function in EndotoxemiaShock, 2002
- Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662Biochemistry, 2002
- Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammationBritish Journal of Pharmacology, 2002
- PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's diseaseTrends in Molecular Medicine, 2001
- Cyclopentenone prostaglandins: New insights on biological activities and cellular targetsMedicinal Research Reviews, 2001
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activationNature, 1998
- Inhibition of nuclear factor κB by prostaglandin A1: An effect associated with heat shock transcription factor activationProceedings of the National Academy of Sciences of the United States of America, 1997
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988